TFRC and cancer: Cancer cells require more iron for their activity and express higher levels of transferrin receptors on their surfaces, resulting in lower serum iron concentrations in some cancers [ 11], with a decrease in serum iron levels potentially serving as an indicator of cancerous activity [ 17].